A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variants.
Journal
HGG advances
ISSN: 2666-2477
Titre abrégé: HGG Adv
Pays: United States
ID NLM: 101772885
Informations de publication
Date de publication:
01 Jul 2024
01 Jul 2024
Historique:
received:
01
04
2024
revised:
27
06
2024
accepted:
27
06
2024
medline:
3
7
2024
pubmed:
3
7
2024
entrez:
3
7
2024
Statut:
aheadofprint
Résumé
Aminoacyl-tRNA synthetases (ARSs) are ubiquitously expressed, essential enzymes that complete the first step of protein translation: ligation of amino acids to cognate tRNAs. Genes encoding ARSs have been implicated in myriad dominant and recessive phenotypes, the latter often affecting multiple tissues but with frequent involvement of the central and peripheral nervous systems, liver, and lungs. Threonyl-tRNA synthetase (TARS1) encodes the enzyme that ligates threonine to tRNA
Identifiants
pubmed: 38956874
pii: S2666-2477(24)00064-2
doi: 10.1016/j.xhgg.2024.100324
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100324Informations de copyright
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.